Printed From BioPortfolio.com

Len Blavatnik mulls stake in Teva

05:41 EST 5 Nov 2017 | Globes

One possibility being considered is of buying Allergan's 10% Teva stake directly.

Original Article: Len Blavatnik mulls stake in Teva

Related Companies
Related Events
Related Clinical Trials
Related PubMed Entries
Related Medications

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Topics

Len Blavatnik mulls stake in Teva

More From BioPortfolio on "Len Blavatnik mulls stake in Teva"

Relevant Topic

News Quicklinks